5 August 2026
Efferon at the Unite for Sepsis Symposium

Thank you to Sepsis Alliance for bringing together such a diverse group of people at the Unite for Sepsis Symposium in the United States.
Over two days, we had the opportunity to engage with physicians, researchers, patient advocates, and sepsis survivors. We are grateful to everyone who visited our stand, attended our CEO Dima Romashin's presentation “Blood Purification in Sepsis: Clinical Outcomes with Multimodal Hemoadsorption,” and shared their insights and experiences.
hashtag#Sepsis is one of the most resource-intensive conditions in the U.S. healthcare system, with annual costs estimated in the tens of billions of dollars. Growing attention to advanced extracorporeal therapies highlights the need for continued innovation and improved treatment pathways. For Efferon, these conversations mark the first, but important, steps in mastering a new clinical environment.
More news
- Efferon at ESICM LIVES 202612 October 2026
- Efferon is now available in India5 October 2026
- World Sepsis Day: Dr. Ruszkai Zoltán21 September 2026
- Efferon at Udon Thani Hospital: A New Look at Hemoadsorption in Sepsis15 September 2026
- WorldSepsisDay 2026: Efferon at the Riga conference14 September 2026
- World Sepsis Day: Prof. Dejan Markovic and Dr. Jovana Avramović Stanisavljević9 September 2026
- Efferon at the 2nd International Sepsis Symposium in Istanbul1 September 2026
- Efferon at Global Recruitment Conference for International Innovative Drugs and Medical Devices 2026 in Boao Lecheng5 July 2026
- Efferon on ESPNIC 202624 June 2026
- Efferon®NEO Receives CE MDR Mark22 April 2026
- Efferon at ISICEM10 April 2026
- Efferon first distributors meeting08 April 2026
- Efferon is now available in Poland11 March 2026
- Efferon®LPS is available in Costa Rica26 February 2026
- Efferon®LPS is now approved in Thailand18 February 2026
- Efferon LPS® incorporated into clinical guidelines of the German Society of Nephrology for therapeutic apheresis10 December 2025
- We’ll see each other in Greece25 November 2025
- Efferon therapies are now available in Armenia!05 November 2025
- Clinical data confirmed the effectiveness of Efferon NEO in children with sepsis30 October 2025
- Efferon LPS has been approved in the Kingdom of Saudi Arabia.18 October 2025
- Extracorporeal removal of antibiotic drugs during Efferon LPS hemoadsorption is predictable and manageable09 October 2025
- Efferon at the 6th Asia Pacific AKI CRRT Congress in Bangkok05 October 2025
- Win a New iPad! Join the Efferon LPS Photo Challenge on LinkedIn12 September 2025
- Efferon LPS hemoadsorption device has been granted regulatory approval in the United Kingdom and Croatia.23 July 2025
- Efferon LPS Now Available in Italy01 July 2025
- Applying Vicenza’s Lessons28 June 2025
- Efferon Expands Its Global Presence23 June 2025
- Efferon expands to new markets with Bertossi partnership06 June 2025
- Efferon LPS becomes available in Romania.25 May 2025
- New distribution agreements in European countries22 July 2024
- Efferon LPS receives CE mark under EU MDR29 April 2024
- Results of LASSO mRCT are published in Shock20 April 2023
- Efferon at LIVES 2022 in Paris03 November 2022
- Efferon has participated in MEDICA30 November 2021
- LASSO multicenter randomized trial launched29 April 2021